Fibrosarcoma Summary

Networked: 4378 relevant articles (108 outcomes, 420 trials/studies) for this Disease

Key Drugs and Agents for Fibrosarcoma

1. Doxorubicin (Adriamycin) : 8 outcomes 10 studies in 71 results : FDA 12 Generic
   
2. Methylcholanthrene : 6 outcomes 32 studies in 370 results : IBA
   
3. 1-phenyl-3,3-dimethyltriazene (PDT) : 4 outcomes 9 studies in 50 results : IBA
   
4. Interleukin-2 (IL2) : 4 outcomes 6 studies in 62 results : IBA
   
5. Cisplatin (Platino) : 3 outcomes 6 studies in 61 results : FDA 6 Generic
   
6. Collagen : 3 outcomes 5 studies in 81 results : IBA
   
7. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor) : 2 outcomes 11 studies in 160 results : IBA
   
8. Cyclophosphamide (Cytoxan) : 2 outcomes 5 studies in 63 results : FDA 10 Generic
   
9. Phosphotransferases (Kinase) : 2 outcomes 4 studies in 45 results : IBA
   
10. Transforming Growth Factor beta (TGF-beta) : 2 outcomes 4 studies in 29 results : IBA
    

Diseases Related to Fibrosarcoma

1. Neoplasms (Cancer)
2. Carcinoma (Carcinomatosis)
3. Adenocarcinoma
4. Neoplasm Metastasis (Metastasis)
5. Melanoma (Melanoma, Malignant)

Key Therapies for Fibrosarcoma

1. Drug Therapy (Chemotherapy) : 6 outcomes 2 studies in 106 results
   
2. Heterologous Transplantation (Xenotransplantation) : 4 outcomes 7 studies in 66 results
   
3. Photochemotherapy (Photodynamic Therapy) : 4 outcomes 3 studies in 30 results
   
4. Immunotherapy : 3 outcomes 3 studies in 33 results
   
5. Injections : 3 outcomes 2 studies in 41 results